Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Pricing as of July 11, 2026
Jastreboff AM, et al
Gao L, Morine Y, Yamada S, Saito Y, Ikemoto T, Tokuda K, et al
Cessation of GLP-1 RA therapy is associated with weight regain, and although current evidence does not provide conclusive findings regarding sarcopenia, the tendency to regain more fat than muscle mass, together with a potential decline in muscle quality, may pose a risk [98]
Tirzepatide is a dual GIP and GLP-1 receptor agonist that often produces larger average weight loss in trials
US$ 25.44
US$ 26.59
US$ 24.95
US$ 22.87
US$ 28.98
